MedTrace Logo

Randomized Controlled Clinical Evaluation to Compare Vanguard Cruciate Retaining and AGC Total Condylar Knee Implants

NCT01064063 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2025-11-26

No results posted yet for this study

Summary

This evaluation is being conducted on the relative new knee system, the Vanguard Cruciate Retaining (CR) to evaluate clinical efficacy of the Vanguard CR components.

Conditions

Interventions

DEVICE

Vanguard CR

The Vanguard CR is a metal and polyethylene total condylar knee system. The system contains three primary components: femoral, tibial, and bearing components, and a peripheral component: the patella button.

DEVICE

AGC knee

The AGC knee is a metal and polyethylene total condylar knee system offering complete component interchangeability.

Sponsors & Collaborators

  • East Sussex Hospitals NHS Trust

    collaborator OTHER

  • Biomet U.K. Ltd.

    collaborator INDUSTRY

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • A. Butler-Manual, FRCS · East Sussex Hospital NHS Trust - Conquest Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-15
Primary Completion
2013-12-15
Completion
2022-05-10

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01064063 on ClinicalTrials.gov